James Adox

Executive Managing Director

Jim Adox is the Executive Managing Director of Venture Investors Health Fund and is located in Ann Arbor, Michigan. He joined Venture Investors in 2006 as a Managing Director and has 25 years of venture capital experience. Jim serves as Chairman of the Board of Directors of HistoSonics, Inc. and serves on the Boards of ViaLase, Inc. and Dvant Pharma Inc. He was previously Chairman of the Board of Directors of Tissue Regeneration Systems (TRS), where he was a co-founder and the Company’s first CEO (acquired by Johnson & Johnson and Medtronic). He was a Board Observer of NeuMoDx, Inc. (acquired by Qiagen) and of LenSx, Inc. (acquired by Alcon.) Jim is the Vice-Chair on the University of Michigan’s College of Engineering Leadership Advisory Board and is a member of the Innovation Partnerships National Advisory Board. Jim previously served on the Board of the Michigan Venture Capital Association and was its Chairman from 2013-2015. Jim has a B S and M S in Mechanical Engineering and an MBA with High Distinction from the University of Michigan. Jim is fluent in Spanish and is a competitive triathlete and five-time Ironman finisher.

Talks About
#venturecapital #entrepreneurship

Preferred Locations
#Northamerica